Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 33342-421

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 33342-421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

765 (Lurasidone 120 mg 30s)

765 (Lurasidone 120 mg 30s)
The text provided is a description of a medication called Lurasidone Hydrochloride Tablets. The tablets have a National Drug Code (NDC) of 3334242307. Each tablet contains 120 mg of Lurasidone Hydrochloride. The usual dosage and other instructions can be found in the package insert. The medication should be stored at temperatures between 20°C to 25°C (68°F to 77°F) with permitted excursions between 15°C to 30°C (59°F to 86°F). The manufacturer of the medication is Macleods Pharma USA, Inc., and it is manufactured by Macleods Pharmaceuticals Ltd at Oxalis Labs in Baddi, Himachal Pradesh, India. For more information, a medication guide is available on the website www.macleodspharma.com.*
FDA Label Image

567 (Lurasidone 120 mg 90s)

567 (Lurasidone 120 mg 90s)
Not available.*
FDA Label Image

111 (Lurasidone 20 mg 30s)

111 (Lurasidone 20 mg 30s)
Lurasidone is a medication that is available in tablet form. The usual dosage is not provided, but it is recommended to refer to the package insert for specific instructions. The tablets should be stored at room temperature, between 68° to 77°F, with excursions permitted between 15° to 30°C. Each film coated tablet contains 20 mg of Lurasidone Hydrochloride. The medication is manufactured by Macleods Pharma USA, Inc. and the code number for manufacturing is HP/DRUGS/12/665. The manufacturing location is Madleods Pharmaceuticals Ltd. at Oxals Labs, Badd, Himachal Pradesh, India.*
FDA Label Image

222 (Lurasidone 20 mg 90s)

222 (Lurasidone 20 mg 90s)
FDA Label Image

333 (Lurasidone 40 mg 30s)

333 (Lurasidone 40 mg 30s)
FDA Label Image

555 (Lurasidone 40 mg 90s)

555 (Lurasidone 40 mg 90s)
FDA Label Image

666 (Lurasidone 60 mg 30s)

666 (Lurasidone 60 mg 30s)
FDA Label Image

666 (Lurasidone 60 mg 90s)

666 (Lurasidone 60 mg 90s)
FDA Label Image

888 (Lurasidone 80 mg 30s)

888 (Lurasidone 80 mg 30s)
FDA Label Image

123 (Lurasidone 80 mg 90s)

123 (Lurasidone 80 mg 90s)
Each film coated tablet contains Lurasidone Hydrochioride 80 mg. This medication is used for the treatment of certain mental/mood disorders such as schizophrenia and bipolar disorder. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F). The usual dosage should be determined according to the instructions provided in the package insert. The medication is manufactured for Macleods Pharma USA, Inc. by Oxals Labs in Baddi, Himachal Pradesh, India. For more information, visit the website www.macleodspharma.com/usa.*
FDA Label Image

198 (Lurasidone Fig 1)

198 (Lurasidone Fig 1)
FDA Label Image

111 (Lurasidone Fig 2)

111 (Lurasidone Fig 2)
FDA Label Image

122 (Lurasidone Fig 3)

122 (Lurasidone Fig 3)
FDA Label Image

115 (Lurasidone Structure)

115 (Lurasidone Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.